Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: A randomized controlled trial

European Journal of Neurology

Volumn 19, Issue 7, 2012, Pages 1030-1036

  Misra, U K ^a   Kalita, J ^a   Chandra, S ^a   Kumar, B ^a   Bansal, V ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cerebral venous sinus thrombosis; Heparin; Low molecular weight heparin; Mortality; Outcome

Indexed keywords

CLOBAZAM; DALTEPARIN; ETIRACETAM; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; VALPROIC ACID;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BARTHEL INDEX; CEREBRAL VENOUS SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOSIS; HUMAN; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PHLEBOGRAPHY; PRIORITY JOURNAL; RADIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINUS THROMBOSIS, INTRACRANIAL; TREATMENT OUTCOME;

EID: 84862332299     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03690.x     Document Type: Article

References (21)

1. Stain M, Schönauer V, Minar E, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3: 2671-2676.
2. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
3. Wasay M, Bakshi R, Bobustuc G, et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis 2008; 17: 49-54.
4. Canhão P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36: 1720-1725.
5. Nagaraja D, Haridas T, Taly AB, et al. Puerperal cerebral venous thrombosis: therapeutic benefit of low dose heparin. Neurol India 1999; 47: 43-46.
6. Coutinho J, De Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011; 8: CD002005.
7. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-600.
8. Van Dongen CJ, Van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004; 4: CD001100 Review. Update in: Cochrane Database Syst Rev. 2010;(9):CD001100.
9. Coutinho JM, Ferro JM, Canhão P, et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 2010; 41: 2575-2580.
10. Côté R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986; 17: 731-737.
11. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61-65.
12. Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. J Stroke Cerebrovasc Dis 2009; 18: 251-258.
13. Kumral E, Polat F, Uzunköprü C, Calli C, Kitiş O. The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis. Eur J Neurol 2012; 19: 537-543.
14. Borhani Haghighi A, Edgell RC, Cruz-Flores S, et al. Mortality of Cerebral Venous-Sinus Thrombosis in a Large National Sample. Stroke 2012; 43: 262-264.
15. Fuentes B, Martínez-Sánchez P, Raya PG, Abenza MJ, Tejedor ED. Cerebral venous sinus thrombosis associated with cerebral hemorrhage: is anticoagulant treatment safe?Neurologist 2011; 17: 208-210.
16. Erkens PM, Prins MH. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2010; 9: CD001100.
17. Fennerty AG, Thomas P, Backhouse G, Bentley P, Campbell IA, Routledge PA. Audit of control of heparin treatment. Br Med J (Clin Res Ed) 1985; 290: 27-28.
18. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993; 119: 874-881.
19. Khealani BA, Wasay M, Saadah M, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke 2008; 39: 2707-2711.
20. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10: 87-111.
21. De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-488.